Edgewise Therapeutics Inc (EWTX)
R&D Expense Growth
11.48%
Quarterly · Period ending:
EWTX R&D Expense Growth
Latest reported11.48%period ending
Latest reported11.48%period ending
EWTX Quarterly R&D Growth (QoQ) (0.00% → 11.48%)
Latest values, visible window
High-resolution chart · PNG
EWTX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 11.4816% | |
| -2.1631% | |
| 16.3127% | |
| 11.6872% | |
| -8.7031% | |
| 1.0641% | |
| 12.8732% | |
| 5.0261% | |
| 10.7821% | |
| 0.0361% | |
| 16.3878% | |
| 21.6115% | |
| -1.5949% | |
| 19.6484% | |
| 19.5624% | |
| 12.0303% | |
| 11.4887% | |
| 22.4032% | |
| -8.0162% | |
| 25.6838% | |
| 46.6604% | |
| 4.3004% | |
| 58.7091% | |
| -11.0195% | |
| 22.6491% | |
| 0% |